The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data fro...

por Pincelli, Carlo, Henninger, Eric, Casset-Semanaz, Florence
Publicado 2006

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15

por Kappos, Ludwig, Kuhle, Jens, Multanen, Juha, Kremenchutzky, Marcelo, Verdun di Cantogno, Elisabetta, Cornelisse, Peter, Lehr, Lorenz, Casset-Semanaz, Florence, Issard, Delphine, Uitdehaag, Bernard M J
Publicado 2015

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

por Freedman, Mark S., De Stefano, Nicola, Barkhof, Frederik, Polman, Chris H., Comi, Giancarlo, Uitdehaag, Bernard M. J., Casset-Semanaz, Florence, Hennessy, Brian, Lehr, Lorenz, Stubinski, Bettina, Jack, Dominic L., Kappos, Ludwig
Publicado 2014

Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes

por De Stefano, Nicola, Comi, Giancarlo, Kappos, Ludwig, Freedman, Mark S, Polman, Chris H, Uitdehaag, Bernard M J, Hennessy, Brian, Casset-Semanaz, Florence, Lehr, Lorenz, Stubinski, Bettina, Jack, Dominic L, Barkhof, Frederik
Publicado 2014

Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient‐level placebo (Standard‐of‐Care) data...

por Goteti, Kosalaram, French, Jonathan, Garcia, Ramon, Li, Ying, Casset‐Semanaz, Florence, Aydemir, Aida, Townsend, Robert, Mateo, Cristina Vazquez, Studham, Matthew, Guenther, Oliver, Kao, Amy, Gastonguay, Marc, Girard, Pascal, Benincosa, Lisa, Venkatakrishnan, Karthik
Publicado 2022